{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:26:41Z","timestamp":1794328001109,"version":"4.9.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Adult B-cell precursor acute lymphoblastic leukemia (B-ALL) is genetically heterogeneous, comprising numerous subtypes. Standard methods leave many patients unclassified and the routine implementation of whole-transcriptome sequencing or whole-genome sequencing is limited. We evaluated a combined workflow of optical genome mapping (OGM) and targeted next-generation sequencing (t-NGS) for the genetic characterization of 100 adult patients with BCR::ABL1-negative B-ALL enrolled in PETHEMA-LAL-19. This approach was compared with protocol genetic testing. The integration of OGM and t-NGS enabled the classification of 84% of patients with BCR::ABL1-negative B-ALL into 15 distinct subtypes, reducing the proportion of B-other\/unclassified cases from 50% to 16%. OGM was useful in identifying BCR::ABL1-like subtype (26% of cases), associated with postinduction minimal\/measurable residual disease (MRD) positivity (72% vs 34%; P = .0011), whereas t-NGS contributed to the detection of mutation-defined subtypes (PAX5 P80R and PAX5 altered), correlated with MRD negativity (91% vs 51%; P = .012). OGM and t-NGS identified genetic patterns of certain subtypes, including a higher prevalence of IKZF1plus in patients with BCR::ABL1-like B-ALL (62% vs 12%; P&amp;lt; .001), JAK-STAT mutations only in patients with CRLF2 rearrangements, and a high prevalence of PAX5 biallelic events (92% vs 2%; P&amp;lt; .001) in PAX5 subtypes. Therefore, the integration of OGM and t-NGS represents a feasible approach that enables comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL, supporting its implementation in routine diagnostic workflows.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020029","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:05:56Z","timestamp":1787947556000},"page":"7299-7310","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive genetic characterization of adult\n                    <i>BCR<\/i>\n                    ::\n                    <i>ABL1<\/i>\n                    -negative B-ALL by optical genome mapping and targeted NGS"],"prefix":"10.1182","volume":"10","author":[{"given":"Josgrey","family":"Navas Acosta","sequence":"first","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-3096","authenticated-orcid":false,"given":"Alberto","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"2Department of Hematology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-7218","authenticated-orcid":false,"given":"\u00c1ngela","family":"Villaverde-Ramiro","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-207X","authenticated-orcid":false,"given":"Sandra","family":"Santos","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-7993","authenticated-orcid":false,"given":"Cristina","family":"Miguel","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayane","family":"Avetisyan","sequence":"additional","affiliation":[{"name":"3Hospital Universitari i Politecnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-3785","authenticated-orcid":false,"given":"Adela","family":"Cisneros","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain"},{"name":"5Institut de recerca contra la Leuc\u00e8mia Josep Carreras, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Puiggros","sequence":"additional","affiliation":[{"name":"6Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain"},{"name":"7Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Costa","sequence":"additional","affiliation":[{"name":"8Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"9Hematopathology Section, Pathology Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"10Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2385","authenticated-orcid":false,"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[{"name":"8Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"9Hematopathology Section, Pathology Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"10Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"11Departament de Fonaments Clinics, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaciones Sanitarias Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-3485","authenticated-orcid":false,"given":"Carolina","family":"Mart\u00ednez-Laperche","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaciones Sanitarias Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-6470","authenticated-orcid":false,"given":"Jordi","family":"Ribera","sequence":"additional","affiliation":[{"name":"5Institut de recerca contra la Leuc\u00e8mia Josep Carreras, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5207-8796","authenticated-orcid":false,"given":"Susana","family":"Barrena","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"10Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"13Cytometry Service, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-7165","authenticated-orcid":false,"given":"Mar\u00eda","family":"Herrero","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"10Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"13Cytometry Service, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-2534","authenticated-orcid":false,"given":"Mireia","family":"Morgades","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain"},{"name":"5Institut de recerca contra la Leuc\u00e8mia Josep Carreras, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-0381","authenticated-orcid":false,"given":"Ricardo","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"14Department of Hematology, Hospital Doce de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-403X","authenticated-orcid":false,"given":"Esperanza","family":"Such","sequence":"additional","affiliation":[{"name":"3Hospital Universitari i Politecnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Espinet","sequence":"additional","affiliation":[{"name":"6Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain"},{"name":"7Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-0104","authenticated-orcid":false,"given":"Isabel","family":"Granada","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain"},{"name":"5Institut de recerca contra la Leuc\u00e8mia Josep Carreras, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-7230","authenticated-orcid":false,"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"10Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"13Cytometry Service, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1042-6024","authenticated-orcid":false,"given":"Josep-Mar\u00eda","family":"Ribera","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Institut Catal\u00e0 d\u2019Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain"},{"name":"5Institut de recerca contra la Leuc\u00e8mia Josep Carreras, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Benito","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9661-9371","authenticated-orcid":false,"given":"Jes\u00fas Mar\u00eda","family":"Hern\u00e1ndez Rivas","sequence":"additional","affiliation":[{"name":"1Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"2Department of Hematology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain"},{"name":"15Department of Medicine, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,30]]},"reference":[{"issue":"11","key":"2026111011015689100_bib1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"2026111011015689100_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"issue":"14","key":"2026111011015689100_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.2023022919","article-title":"Genetic subtypes of B-cell acute lymphoblastic leukemia in adults","volume":"145","author":"Passet","year":"2025","journal-title":"Blood"},{"issue":"20","key":"2026111011015689100_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2026111011015689100_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2018-10-882142","article-title":"PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome","volume":"133","author":"Passet","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2026111011015689100_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"24","key":"2026111011015689100_bib7","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood.2022015444","article-title":"Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia","volume":"139","author":"Kimura","year":"2022","journal-title":"Blood"},{"issue":"11","key":"2026111011015689100_bib8","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41375-021-01199-0","article-title":"Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group","volume":"35","author":"Hirabayashi","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"2026111011015689100_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2026111011015689100_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"25","key":"2026111011015689100_bib11","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the children's oncology group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"issue":"7","key":"2026111011015689100_bib12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"2026111011015689100_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"issue":"3","key":"2026111011015689100_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41375-021-01448-2","article-title":"Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study","volume":"36","author":"Moorman","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"2026111011015689100_bib15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","article-title":"ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"2026111011015689100_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.17869","article-title":"Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification","volume":"196","author":"Schwab","year":"2022","journal-title":"Br J Haematol"},{"issue":"7","key":"2026111011015689100_bib17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3324\/haematol.2018.204974","article-title":"Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"issue":"13","key":"2026111011015689100_bib18","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/bloodadvances.2022009179","article-title":"Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing","volume":"7","author":"Migita","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"2026111011015689100_bib19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/bjh.20056","article-title":"RNA-sequencing: a reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia","volume":"206","author":"Vicente-Garc\u00e9s","year":"2025","journal-title":"Br J Haematol"},{"key":"2026111011015689100_bib20","doi-asserted-by":"crossref","first-page":"e2400788","DOI":"10.1200\/PO-24-00788","article-title":"Challenging conventional diagnostic methods by comprehensive molecular diagnostics: a nationwide prospective comparison in children with ALL","volume":"9","author":"Boer","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"2026111011015689100_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41375-022-01806-8","article-title":"Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia","volume":"37","author":"Ryan","year":"2023","journal-title":"Leukemia"},{"issue":"15","key":"2026111011015689100_bib22","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1182\/bloodadvances.2022008992","article-title":"Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia","volume":"7","author":"Leongamornlert","year":"2023","journal-title":"Blood Adv"},{"key":"2026111011015689100_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-981-13-6037-4_7","article-title":"Bionano genome mapping: high-throughput, ultra-long molecule genome analysis system for precision genome assembly and haploid-resolved structural variation discovery","volume":"1129","author":"Bocklandt","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2026111011015689100_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ajh.27688","article-title":"Integration of optical genome mapping in the cytogenomic and molecular work-up of hematological malignancies: expert recommendations from the international consortium for optical genome mapping","volume":"100","author":"Kanagal-Shamanna","year":"2025","journal-title":"Am J Hematol"},{"issue":"8","key":"2026111011015689100_bib25","doi-asserted-by":"crossref","first-page":"e925","DOI":"10.1097\/HS9.0000000000000925","article-title":"Optical genome mapping identifies novel recurrent structural alterations in childhood ETV6::RUNX1+ and high hyperdiploid acute lymphoblastic leukemia","volume":"7","author":"Brandes","year":"2023","journal-title":"Hemasphere"},{"issue":"5","key":"2026111011015689100_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.26487","article-title":"Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping","volume":"97","author":"Rack","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"2026111011015689100_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/cancers15010035","article-title":"Optical genome mapping for comprehensive assessment of chromosomal aberrations and discovery of new fusion genes in pediatric B-acute lymphoblastic leukemia","volume":"15","author":"Gao","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2026111011015689100_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3324\/haematol.2023.284115","article-title":"Deciphering the molecular complexity of the IKZF1plus genomic profile using optical genome mapping","volume":"109","author":"L\u00fchmann","year":"2023","journal-title":"Haematologica"},{"issue":"3","key":"2026111011015689100_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/genes14030686","article-title":"Optical genome mapping reveals and characterizes recurrent aberrations and new fusion genes in adult ALL","volume":"14","author":"Vieler","year":"2023","journal-title":"Genes (Basel)"},{"issue":"11","key":"2026111011015689100_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/gcc.22486","article-title":"Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms","volume":"56","author":"Ribera","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"2026111011015689100_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","article-title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","volume":"129","author":"Theunissen","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2026111011015689100_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41408-020-0308-3","article-title":"A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics","volume":"10","author":"S\u00e1nchez","year":"2020","journal-title":"Blood Cancer J"},{"issue":"19","key":"2026111011015689100_bib33","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2023020794","article-title":"Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2026111011015689100_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/jpm10030137","article-title":"Comprehensive custom NGS panel validation for the improvement of the stratification of b-acute lymphoblastic leukemia patients","volume":"10","author":"Monta\u00f1o","year":"2020","journal-title":"J Pers Med"},{"issue":"1","key":"2026111011015689100_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3324\/haematol.2015.136366","article-title":"Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis","volume":"102","author":"Herold","year":"2017","journal-title":"Haematologica"},{"issue":"23","key":"2026111011015689100_bib36","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood.V126.23.2610.2610","article-title":"Three steps to the diagnosis of adult Ph-like ALL","volume":"126","author":"Fasan","year":"2015","journal-title":"Blood"},{"issue":"21","key":"2026111011015689100_bib37","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood.2023023120","article-title":"Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain","volume":"143","author":"van Outersterp","year":"2024","journal-title":"Blood"},{"issue":"11","key":"2026111011015689100_bib38","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41416-025-03204-0","article-title":"Benchmarking standard-of-care and emerging genomic approaches to enhance diagnosis in pediatric acute lymphoblastic leukemia","volume":"133","author":"Gil","year":"2025","journal-title":"Br J Cancer"},{"issue":"24","key":"2026111011015689100_bib39","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.2021014723","article-title":"Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL","volume":"139","author":"Passet","year":"2022","journal-title":"Blood"},{"issue":"8","key":"2026111011015689100_bib40","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41375-019-0430-z","article-title":"PAX5 biallelic genomic alterations define a novel subtype of B-cell precursor acute lymphoblastic leukemia","volume":"33","author":"Bastian","year":"2019","journal-title":"Leukemia"},{"issue":"23","key":"2026111011015689100_bib41","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1182\/bloodadvances.2021004895","article-title":"Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"2026111011015689100_bib42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026111011015689100_bib43","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"7","author":"Lilljebj\u00f6rn","year":"2016","journal-title":"Nat Commun"},{"issue":"12","key":"2026111011015689100_bib44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"2026111011015689100_bib45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41375-022-01799-4","article-title":"Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial","volume":"37","author":"Schwab","year":"2023","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7299\/2597706\/blooda_adv-2026-020029-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7299\/2597706\/blooda_adv-2026-020029-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:02:06Z","timestamp":1794326526000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/21\/7299\/570597\/Comprehensive-genetic-characterization-of-adult"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,30]]},"references-count":45,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,11,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020029","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,10]]},"published":{"date-parts":[[2026,10,30]]}}}